Spago Nanomedical AB (7UX) Stock Statistics & Valuation Metrics

Spago Nanomedical AB has a market cap or net worth of €8.68M. The enterprise value is €103.00M.

Spago Nanomedical AB has 661,572,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

Spago Nanomedical AB’s return on equity (ROE) is -0.98 and return on invested capital (ROIC) is -99.98%.

The current PE Ratio of Spago Nanomedical AB is ―. Spago Nanomedical AB’s PEG ratio is 0.04.

In the last 12 months, Spago Nanomedical AB had revenue of 1.91M and earned -32.51M in profits. Earnings per share was -0.11.

In the last 12 months, operating cash flow was -29.76M and capital expenditures -229.00K, giving a free cash flow of -29.76M billion.

Spago Nanomedical AB pays an annual dividend of ―, resulting in a dividend yield of ―

Spago Nanomedical AB upcoming earnings date is Jan 29, 2026, Before Open (Confirmed).

Spago Nanomedical AB as a current ratio of 6.58, with Debt / Equity ratio of 0.00%

In the past 12 months, Spago Nanomedical AB has paid 0.00 in taxes.

Spago Nanomedical AB EV to EBITDA ratio is -0.76, with an EV/FCF ratio of -0.73.

Spago Nanomedical AB has €18.52M in cash and marketable securities with €0.00 in debt, giving a net cash position of €18.52M billion.

Gross margin is -782.84%, with operating margin of -1764.15%, and net profit margin of -1701.15%.

The average price target for Spago Nanomedical AB is ―, which is 11.43% higher than the current price. The consensus rating is ―